<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>31(1)</volume><submitter>Hermantara R</submitter><funding>Indonesia Endowment Fund Scholarship</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>The field of genome editing has been revolutionized by the development of an easily programmable editing tool, the CRISPR-Cas9. Despite its promise, off-target activity of Cas9 posed a great disadvantage for genome editing purposes by causing DNA double strand breaks at off-target locations and causing unwanted editing outcomes. Furthermore, for gene integration applications, which introduce transgene sequences, integration of transgenes to off-target sites could be harmful, hard to detect, and reduce faithful genome editing efficiency.&lt;h4>Method&lt;/h4>Here we report the development of a multicolour fluorescence assay for studying CRISPR-Cas9-directed gene integration at an endogenous locus in human cell lines. We examine genetic integration of reporter genes in transiently transfected cells as well as puromycin-selected stable cell lines to determine the fidelity of multiple CRISPR-Cas9 strategies.&lt;h4>Result&lt;/h4>We found that there is a high occurrence of unwanted DNA integration which tarnished faithful knock-in efficiency. Integration outcomes are influenced by the type of DNA DSBs, donor design, the use of enhanced specificity Cas9 variants, with S-phase regulated Cas9 activity. Moreover, restricting Cas9 expression with a self-cleaving system greatly improves knock-in outcomes by substantially reducing the percentage of cells with unwanted DNA integration.&lt;h4>Conclusion&lt;/h4>Our results highlight the need for a more stringent assessment of CRISPR-Cas9-mediated knock-in outcomes, and the importance of careful strategy design to maximise efficient and faithful transgene integration.</pubmed_abstract><journal>Journal of biomedical science</journal><pagination>32</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10964699</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Improving CRISPR-Cas9 directed faithful transgene integration outcomes by reducing unwanted random DNA integration.</pubmed_title><pmcid>PMC10964699</pmcid><pubmed_authors>West K</pubmed_authors><pubmed_authors>Jeantet V</pubmed_authors><pubmed_authors>Guerrini I</pubmed_authors><pubmed_authors>Richmond L</pubmed_authors><pubmed_authors>Hermantara R</pubmed_authors><pubmed_authors>Chilaka S</pubmed_authors><pubmed_authors>Taqi AF</pubmed_authors><pubmed_authors>West A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Improving CRISPR-Cas9 directed faithful transgene integration outcomes by reducing unwanted random DNA integration.</name><description>&lt;h4>Background&lt;/h4>The field of genome editing has been revolutionized by the development of an easily programmable editing tool, the CRISPR-Cas9. Despite its promise, off-target activity of Cas9 posed a great disadvantage for genome editing purposes by causing DNA double strand breaks at off-target locations and causing unwanted editing outcomes. Furthermore, for gene integration applications, which introduce transgene sequences, integration of transgenes to off-target sites could be harmful, hard to detect, and reduce faithful genome editing efficiency.&lt;h4>Method&lt;/h4>Here we report the development of a multicolour fluorescence assay for studying CRISPR-Cas9-directed gene integration at an endogenous locus in human cell lines. We examine genetic integration of reporter genes in transiently transfected cells as well as puromycin-selected stable cell lines to determine the fidelity of multiple CRISPR-Cas9 strategies.&lt;h4>Result&lt;/h4>We found that there is a high occurrence of unwanted DNA integration which tarnished faithful knock-in efficiency. Integration outcomes are influenced by the type of DNA DSBs, donor design, the use of enhanced specificity Cas9 variants, with S-phase regulated Cas9 activity. Moreover, restricting Cas9 expression with a self-cleaving system greatly improves knock-in outcomes by substantially reducing the percentage of cells with unwanted DNA integration.&lt;h4>Conclusion&lt;/h4>Our results highlight the need for a more stringent assessment of CRISPR-Cas9-mediated knock-in outcomes, and the importance of careful strategy design to maximise efficient and faithful transgene integration.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-04T23:53:46.688Z</modification><creation>2025-04-04T23:53:46.688Z</creation></dates><accession>S-EPMC10964699</accession><cross_references><pubmed>38532479</pubmed><doi>10.1186/s12929-024-01020-x</doi></cross_references></HashMap>